Related Experiment Video

Updated: May 15, 2026

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

Possible aspects of using cultured stem cell of laboratory primates in experimental medicine

V Z Agrba1, V A Porkhanov, A G Konoplyannikov

  • 1Research Institute of Medical Primatology, Russian Academy of Medical Sciences, Sochi, Russia. agrba_vz@mail.ru

Bulletin of Experimental Biology and Medicine
|January 19, 2013
PubMed

Insights

Researchers isolated mesenchymal stem cells from monkeys and found they protected against heart damage caused by doxorubicin, a chemotherapy drug. These stem cells show promise for treating drug-induced cardiomyopathy.

Area of Science:

  • Stem cell research
  • Cardiology
  • Primate models

Background:

  • Mesenchymal stem cells (MSCs) are multipotent stromal cells with immunomodulatory and regenerative properties.
  • Anthracycline chemotherapy, such as doxorubicin, can cause significant cardiotoxicity, leading to cardiomyopathy.
  • Identifying reliable sources of MSCs for therapeutic applications is crucial.

Purpose of the Study:

  • To describe the isolation and culturing methods for mesenchymal stem cells from three primate species.
  • To characterize these primate-derived MSCs using flow cytometry.
  • To investigate the potential cardioprotective effects of these MSCs against doxorubicin-induced cardiomyopathy.

Main Methods:

  • Isolation and in vitro culturing of mesenchymal stem cells from Macaca mulatta, Papio hamadryas, and Macaca fascicularis.
  • Flow cytofluorometry analysis to determine cell surface marker expression (CD34, CD45, HLA-DR, CD90).
  • Induction of cardiomyopathy in a model using doxorubicin, followed by assessment of MSC treatment effects.

Main Results:

  • Successful isolation and culturing of mesenchymal stem cells from the specified monkey species.
  • Primate MSCs exhibited characteristic surface marker profiles, notably expressing CD90 (78-98%) while lacking CD34, CD45, and HLA-DR.
  • Cultured MSCs demonstrated cardioprotective effects in the doxorubicin-induced cardiomyopathy model.

Conclusions:

  • Mesenchymal stem cells from Macaca mulatta, Papio hamadryas, and Macaca fascicularis can be effectively isolated and cultured.
  • These primate MSCs possess a distinct immunophenotype suitable for further investigation.
  • The study provides evidence for the cardioprotective potential of these MSCs, suggesting a possible therapeutic strategy for anthracycline-induced cardiomyopathy.

More Related Videos

Generation and Maintenance of Primate Induced Pluripotent Stem Cells Derived from Urine07:46

Generation and Maintenance of Primate Induced Pluripotent Stem Cells Derived from Urine

Published on: July 28, 2023

Targeted Microinjection and Electroporation of Primate Cerebral Organoids for Genetic Modification11:44

Targeted Microinjection and Electroporation of Primate Cerebral Organoids for Genetic Modification

Published on: March 24, 2023

Related Concept Videos

Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...